Skip to main content

Bell Investment Advisors, Inc

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1890149 ORINDA, CA

Position in HALO

as of Mar 31, 2026 · filed Apr 17, 2026
Position Value
$11,439
-$1,078 QoQ
Shares Held
177
-4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bell Investment Advisors, Inc holds $351,465 across 64 Biotechnology names. HALO ranks #8 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 HALO
Halozyme Therapeutics, Inc.
This page
177 $11,439

All Filings in HALO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,439 177
2025-12-31 $12,517 186
2025-09-30 $14,227 194
2025-06-30 $10,091 194
2025-03-31 $12,379 194
2024-12-31 $8,462 177
2024-09-30 $10,017 175
2024-06-30 $9,163 175
2024-03-31 $5,125 126
2023-12-31 $4,620 125
2023-09-30 $3,934 103
2023-06-30 $3,715 103
2023-03-31 $3,971 104
2022-12-31 $7,397 130
2022-09-30 $4,665 118
2022-06-30 $5,104 116
2021-12-31 $2,050 51
2021-09-30 $3,010 74